Investitionsthese
3BFuture Health Fund invests in US, European, and Israeli startups focused on life-changing treatments, prioritizing oncology and rare diseases with strong unmet patient needs. The fund targets companies with robust science, experienced management, and potential for transformative impact.
Investitionsphase
Series A and earlier-stage investments
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Early-stage and clinical development-stage companies with first-in-class assets, revolutionary insights, and unmet patient needs
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€11.040.000 - €11.040.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
